Neuraxpharm Boosts Branded Business With Established Sanofi Portfolios

Latest Acquisition Should See Firm’s Annual Gross Sales Expand To €600m

 
• By Chloe Kent
  
Graphic depiction of central nervous system
Neuraxpharm has purchased two portfolios of CNS, pain and vascular disease products • Source: Shutterstock

More from Deals

More from Business